AR013817A1 - NUCLEIC ACID, VECTOR, PROCEDURE FOR THE PRODUCTION OF GLICOPROTEIN G FROM RABIA VIRUS, GLICOPROTEIN, VEGETABLE CELLS, CHEMICAL OR TRANSGENIC PLANT, GRAINS OF TRANSGENIC PLANTS, MONOCLONAL ANTIBODIES, LABEL COMPOSITION, COMPUTERIZATION - Google Patents
NUCLEIC ACID, VECTOR, PROCEDURE FOR THE PRODUCTION OF GLICOPROTEIN G FROM RABIA VIRUS, GLICOPROTEIN, VEGETABLE CELLS, CHEMICAL OR TRANSGENIC PLANT, GRAINS OF TRANSGENIC PLANTS, MONOCLONAL ANTIBODIES, LABEL COMPOSITION, COMPUTERIZATIONInfo
- Publication number
- AR013817A1 AR013817A1 ARP970101956A ARP970101956A AR013817A1 AR 013817 A1 AR013817 A1 AR 013817A1 AR P970101956 A ARP970101956 A AR P970101956A AR P970101956 A ARP970101956 A AR P970101956A AR 013817 A1 AR013817 A1 AR 013817A1
- Authority
- AR
- Argentina
- Prior art keywords
- glicoprotein
- virus
- grains
- vector
- nucleic acid
- Prior art date
Links
- 230000009261 transgenic effect Effects 0.000 title abstract 4
- 241000700605 Viruses Species 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 108020004707 nucleic acids Proteins 0.000 title abstract 2
- 102000039446 nucleic acids Human genes 0.000 title abstract 2
- 150000007523 nucleic acids Chemical class 0.000 title abstract 2
- 239000000126 substance Substances 0.000 title 1
- 235000013311 vegetables Nutrition 0.000 title 1
- 241000711798 Rabies lyssavirus Species 0.000 abstract 3
- 108091026890 Coding region Proteins 0.000 abstract 2
- 102000003886 Glycoproteins Human genes 0.000 abstract 2
- 108090000288 Glycoproteins Proteins 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108091006027 G proteins Proteins 0.000 abstract 1
- 102000030782 GTP binding Human genes 0.000 abstract 1
- 108091000058 GTP-Binding Proteins 0.000 abstract 1
- 108010076504 Protein Sorting Signals Proteins 0.000 abstract 1
- 108010046722 Thrombospondin 1 Proteins 0.000 abstract 1
- 102100036034 Thrombospondin-1 Human genes 0.000 abstract 1
- 230000000295 complement effect Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 235000013305 food Nutrition 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
- C12N15/8258—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon for the production of oral vaccines (antigens) or immunoglobulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/20011—Rhabdoviridae
- C12N2760/20111—Lyssavirus, e.g. rabies virus
- C12N2760/20122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Plant Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Virology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Acido nucleico, que comprende una secuencia codificadora quimérica que comprende una secuencia codificadora quimérica que comprende por una parte unasecuencia que codifica para la proteína Gmadura del virus de la rabia o de un virusrelacionad o con el virus de la rabia, o para una proteína análoga, y porotra parte, una secuencia que codifica para un péptido senal N-terminal distinto del que está naturalmente asociado con la proteína G viral, o lassecuenciascomplementarias de dic has secunecias codificadoras; vector, procedimiento para la produccion de la glicoproteína G del virus de la rabia,glicoproteína, células vegetales, planta quimérica o transgénica, granos de plantas transgénicas,anticuerpos monoclonales o policlonales, composicionfarmacéutica, utilizacion de la glicoproteína para la preparacion de un medicamento, y un producto alimenticio.Nucleic acid, which comprises a chimeric coding sequence comprising a chimeric coding sequence comprising on the one hand a sequence encoding for the Gmadura protein of the rabies virus or of a virus related to rabies virus, or for an analogous protein, and on the other hand, a sequence coding for an N-terminal signal peptide other than that which is naturally associated with the viral G protein, or the complementary sequences of the coding seconds; vector, procedure for the production of the glycoprotein G of rabies virus, glycoprotein, plant cells, chimeric or transgenic plant, grains of transgenic plants, monoclonal or polyclonal antibodies, pharmaceutical composition, use of glycoprotein for the preparation of a medicament, and A food product.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9606029A FR2748480B1 (en) | 1996-05-09 | 1996-05-09 | TRANSGENIC PLANTS EXPRESSING Rabies GLYCOPROTEIN G, AND GLYCOPROTEINS THUS OBTAINED |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR013817A1 true AR013817A1 (en) | 2001-01-31 |
Family
ID=9492145
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP970101956A AR013817A1 (en) | 1996-05-09 | 1997-09-05 | NUCLEIC ACID, VECTOR, PROCEDURE FOR THE PRODUCTION OF GLICOPROTEIN G FROM RABIA VIRUS, GLICOPROTEIN, VEGETABLE CELLS, CHEMICAL OR TRANSGENIC PLANT, GRAINS OF TRANSGENIC PLANTS, MONOCLONAL ANTIBODIES, LABEL COMPOSITION, COMPUTERIZATION |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0910650A1 (en) |
| AR (1) | AR013817A1 (en) |
| AU (1) | AU2965797A (en) |
| CA (1) | CA2254115A1 (en) |
| FR (1) | FR2748480B1 (en) |
| WO (1) | WO1997043428A1 (en) |
| ZA (1) | ZA974037B (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000068392A1 (en) * | 1999-05-11 | 2000-11-16 | The Board Of Trustees Of The University Of Illinois | Plant-derived antigens against respiratory syncytial virus |
| WO2006016380A2 (en) * | 2004-08-13 | 2006-02-16 | Council Of Scientific And Industrial Research | A chimeric g protein based rabies vaccine |
| WO2008063982A2 (en) * | 2006-11-13 | 2008-05-29 | Procell Corp | High mannose glycoprotein epitopes |
| MY166220A (en) * | 2011-06-13 | 2018-06-22 | Medicago Inc | Rabies virus like particle production in plants |
| CN109111507B (en) * | 2017-08-22 | 2021-12-24 | 浙江派迪畅科技发展有限公司 | Virus recombinant glycoprotein and eukaryotic cell high-efficiency expression method and application thereof |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1985001516A1 (en) * | 1983-10-03 | 1985-04-11 | Transgene S.A. | Vectors for the expression of an antigenic protein of rabies in eucaryotic cells and application thereof to the preparation of a vaccine |
| NL8901932A (en) * | 1989-07-26 | 1991-02-18 | Mogen Int | PRODUCTION OF heterologous PROTEINS IN PLANTS OR PLANTS. |
| AU7583691A (en) * | 1990-03-05 | 1991-10-10 | Upjohn Company, The | Protein expression via seed specific regulatory sequences |
| ATE290087T1 (en) * | 1990-06-15 | 2005-03-15 | Syngenta Participations Ag | NEW SIGNAL SEQUENCES |
| US5612487A (en) * | 1991-08-26 | 1997-03-18 | Edible Vaccines, Inc. | Anti-viral vaccines expressed in plants |
| WO1996012801A1 (en) * | 1994-10-24 | 1996-05-02 | The Texas A & M University System | Oral immunization with transgenic plants |
| JPH08269092A (en) * | 1995-03-31 | 1996-10-15 | Chemo Sero Therapeut Res Inst | Rabies vaccine produced by recombinant gene in escherichia coli |
| WO1996040229A1 (en) * | 1995-06-07 | 1996-12-19 | Thomas Jefferson University | Vaccines synthesized by transgenic plants |
-
1996
- 1996-05-09 FR FR9606029A patent/FR2748480B1/en not_active Expired - Fee Related
-
1997
- 1997-05-07 CA CA002254115A patent/CA2254115A1/en not_active Abandoned
- 1997-05-07 AU AU29657/97A patent/AU2965797A/en not_active Abandoned
- 1997-05-07 EP EP97924066A patent/EP0910650A1/en not_active Withdrawn
- 1997-05-07 WO PCT/FR1997/000827 patent/WO1997043428A1/en not_active Application Discontinuation
- 1997-05-09 ZA ZA9704037A patent/ZA974037B/en unknown
- 1997-09-05 AR ARP970101956A patent/AR013817A1/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO1997043428A1 (en) | 1997-11-20 |
| FR2748480A1 (en) | 1997-11-14 |
| AU2965797A (en) | 1997-12-05 |
| EP0910650A1 (en) | 1999-04-28 |
| ZA974037B (en) | 1998-01-08 |
| FR2748480B1 (en) | 1998-09-04 |
| CA2254115A1 (en) | 1997-11-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR049214A1 (en) | PEPTIDES OF TRANSIT TO PLASTIDES | |
| WO1998020133A3 (en) | Proteins with enhanced levels of essential amino acids | |
| AU2001253247A1 (en) | Signal transduction stress-related proteins and use in plants | |
| AR248044A1 (en) | Design, cloning and expression of humanized monoclonal antibodies against human interleukin-5. | |
| PT703983E (en) | ADJUSTMENT OF PLANT GROWTH | |
| IL173253A0 (en) | Polypeptides for inducing a protective immune response against staphylococcus aureus | |
| ES2181678T3 (en) | SEQUENCE OF AADN SYNTHETICS THAT HAVE INSECTICIATED ACTIVITY POTENTIATED IN CORN. | |
| TR199900145T2 (en) | Frozen food product containing heat stable antifreeze protein. | |
| NO940736D0 (en) | DNA sequences encoding gelonin polypeptide | |
| AR060435A1 (en) | POLYPEPTIDES RELATED TO ESTERS AND METHODS FOR USE IN PLANTS | |
| HUP0100410A2 (en) | Frozen food product | |
| AR013817A1 (en) | NUCLEIC ACID, VECTOR, PROCEDURE FOR THE PRODUCTION OF GLICOPROTEIN G FROM RABIA VIRUS, GLICOPROTEIN, VEGETABLE CELLS, CHEMICAL OR TRANSGENIC PLANT, GRAINS OF TRANSGENIC PLANTS, MONOCLONAL ANTIBODIES, LABEL COMPOSITION, COMPUTERIZATION | |
| ES2280352T3 (en) | GENES OF LEAFY COTILEDON2 AND ITS USES. | |
| DE69900756T2 (en) | USE OF HMG PROTEINS FOR THE PRODUCTION OF MEDICINAL PRODUCTS WITH A CYTOTOXIC EFFECT | |
| BR9713984A (en) | Anti-freeze polypeptides, isolated nucleic acid sequence, process to obtain polypeptides, antibody, food product, process to produce the same, use of the polypeptide, and, microorganisms, cell line, or plant. | |
| MX173743B (en) | FOOD PRODUCT OF VARIOUS COMPONENTS WITH PROTECTIVE BARRIER, PROCEDURE FOR THEIR OBTAINING AND COMPOSITION FOR ITS REALIZATION | |
| AR064252A1 (en) | PLANTS THAT PRESENT ACHIEVED CHARACTERISTICS RELATED TO PERFORMANCE AND A METHOD TO PRODUCE THE SAME | |
| GB0608368D0 (en) | Process for making Oligopeptides | |
| AR002742A1 (en) | ADIPOSE TYPE REGULATORY PROTEIN, PROCEDURE TO PRODUCE SUCH PROTEIN, PHARMACEUTICAL FORMULATIONS INCLUDING IT, ISOLATED DNA MOLECULES THAT CODES SUCH PROTEIN, VECTOR AND RECOMBINANT CELLS THAT INCLUDE SUCH DNA | |
| NZ319425A (en) | Polynucleic acids that encode a mutant or chimeric lantibiotic, nisin or subtilin that have enhanced stability and activity | |
| HK1006727A1 (en) | Protein structure of the plant toxin gelonin | |
| AR051655A1 (en) | VESICULAR TRANSIT POLYPEPTIDES RELATED TO STRESS AND METHODS OF USE IN PLANTS | |
| NO971110L (en) | Process for Preparation of a Modified Collagen Induced Platelet Aggregation Inhibitor, Pallidipine | |
| AR053638A1 (en) | POLYPEPTIDES RELATED TO STRESS OF PROPEINAQUINASE SIMILAR TO LECITINE AND METHODS OF USE IN PLANTS | |
| DE69504795T2 (en) | METHODS FOR SYNTHESIS AND PURIFICATION OF PEPTIDES |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |